Injective Aims for $188 Following Accumulation in the $6 to $9 Range
Written by Ohris M. Greyoon, Blockchain & Crypto Expert
Source: Coinmarketcap
Updated: Sep 01 2025
Should l Buy INJ?
Injective's Price Movement and Breakout Potential
- Current Price and Accumulation Range: Injective (INJ) is currently priced at approximately $13.12, with analysts identifying an accumulation range between $6 and $9, which is seen as a critical entry point for potential breakout strength.
- Projected Price Targets: Analysts have outlined three phases for Injective's price trajectory. The second phase includes target prices of $30, $50, and $70, while the third phase anticipates a euphoric surge beyond $100.
Historical Performance and Technical Analysis
- Past Corrections and Rebounds: Injective has experienced significant corrections in previous cycles, including a 95.56% drop followed by an 87.92% decline. Despite these setbacks, the token rebounded with gains exceeding 4,073% in earlier cycles, indicating a cyclical pattern that supports the current breakout forecast.
- Technical Structure: The technical chart reveals a repeating pattern with key waves labeled 1, 2, and 3. A breakout above the resistance trendline is necessary to confirm the next major upward impulse, with projections suggesting a potential rise to $188.81, representing over 2,072% gains if momentum is maintained.
Market Dynamics and Future Outlook
- Volume and Market Interest: Recent trading volumes around 14.93 million indicate heightened interest in Injective, with the current price near $13.12 suggesting a pivotal moment for potential breakout confirmation.
- Phases of Growth: The outlined phases provide a clear roadmap for traders, with the accumulation zone at $6–$9 serving as a springboard for future growth. The mid-term targets of $30, $50, and $70 are seen as psychological resistance points that could attract increased trading volume.
- Euphoria Stage: The third phase anticipates a euphoria stage above $100, framed as a statistical probability based on historical performance. Analysts believe that if Injective follows its past patterns, reaching triple digits is a realistic expectation.
Conclusion
- Community Sentiment: The trading community remains optimistic about Injective's potential, with discussions focusing on the transition from accumulation to exponential growth. The cyclical structure and defined targets continue to attract attention from both traders and analysts, reinforcing the likelihood of a significant breakout.
Get Real-Time Alerts for Any Crypto Movement
Technical Analysis for INJ
Technical Sentiment Analysis for Injective (INJ) As of , Injective (INJ) is exhibiting a Sell technical sentiment. Our proprietary analysis, which aggregates 3 technical signals, shows that 0 indicators are flashing buy, while 3 are indicating sell.
Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for INJ stands at -, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -, providing a Neutral signal for short-term momentum. Other oscillators like the Stochastic Oscillator at - and the Commodity Channel Index (CCI) at - further confirm a - outlook for the stock.
Support, Resistance & Moving Averages From a structural perspective, INJ is trading below its 60-day moving average of $- and below its 200-day long-term moving average of $-. Key price levels to watch include the immediate resistance at $- and strong support at $-. A break above $- could signal a bull continuation, while falling below $- may test the next Fibonacci floor at $-.
Injective (INJ) Support & Resistance Level
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 1.327 | 1.989 | 2.685 | 3.347 | 4.043 | 4.705 | 5.401 |
| Fibonacci | 1.989 | 2.507 | 2.828 | 3.347 | 3.865 | 4.186 | 4.705 |
About INJ
Injective is the first and only blockchain built for finance. It is an open, interoperable layer-one blockchain powering next-generation finance applications, including DeFi, RWAs, AI, decentralized exchanges, prediction markets, lending protocols, and more.Injective uniquely provides powerful core financial infrastructure primitives that applications can leverage, including a fully decentralized MEV-resistant on-chain orderbook. Developers can utilize Injective’s plug-and-play modules to rapidly deploy applications that could take years on other chains. Injective is also one of the most interoperable L1s ever created which is fully compatible with major chains such as Ethereum and Solana.Injective also provides a next-generation, highly interoperable smart contract platform based on Wasm 2.0, with advanced interchain capabilities. Injective utilizes a custom implementation of the Tendermint Proof-of-Stake consensus mechanism, providing instant transaction finality with lightning speed – sub second block times (0.6s) while sustaining enormous throughput (25,000+ TPS). Injective currently is also leading new forms of innovation across a number of verticals such as its pioneering work to integrate artificial intelligence with on-chain finance.Injective has achieved a historic milestone of over 1 billion transactions to date with one of the fastest chains built to date. The Injective ecosystem includes 100+ projects and over 500,000 community members globally. Injective was originally incubated by Binance and is also backed by a group of prominent investors including Pantera Capital, Jump Crypto, and Mark Cuban.
About the author
Ohris M. Greyoon
Ohris M. Greyoon holds a Master’s in Computer Science from MIT and has 10 years of experience in blockchain technology and cryptocurrency markets. A pioneer in decentralized finance (DeFi) analysis, he leads Intellectia’s Crypto News, offering cutting-edge insights into digital assets.
